Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Poddar Pigments Limited (PODDARMENT.NS)
Mumbai, IN
Poddar Pigments Limited, established in 1991 and based in Mumbai, India, specializes in the production and distribution of color and additive masterbatches. These essential compounds are primarily utilized in the dope dyeing process for synthetic fibers, including polyester, polypropylene, and polyamide, as well as for a wide array of plastic applications. The company's diverse product portfolio for the plastics and packaging sectors encompasses various additive masterbatches, materials for films, packaging solutions, injection/blow/roto molded items, pipe extrusions, cables, PET preforms and bottles, and other advanced plastic solutions. Additionally, Poddar Pigments offers a range of engineering compounds under its MASTERPLUS brand, featuring series such as carboplus, butoplus, nyloplus, and polyplus. These specialized products find extensive application across numerous industries, including textiles (for home furnishings, upholstery, apparel, carpets, and hosiery-wear), automotive components, luggage, lamination fabrics, PP strapping, and non-woven and spun-bonded fabrics. While primarily catering to the Indian market, the company also engages in international exports.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.95% | -5.60% | -5.84% | -1.28% | -6.28% | -7.50% | -21.96% | -20.01% | +2.06% | +19.79% | +19.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+1.7% Q1'26: +15.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-35.4% Q1'26: -7.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+0.5% Q1'26: +34.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.8% Q1'26: +1.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.2% Q1'26: +2.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.26× ★ Q1'26: 0.36× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2013 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.76B
est: 2.59B (+6.4%)
|
3.18B
est: 3.36B (-5.3%)
|
3.26B
est: 3.44B (-5.2%)
|
3.29B
est: 3.49B (-5.6%)
|
3.34B
est: 3.57B (-6.5%)
|
3.57B
est: 3.67B (-2.8%)
|
3.51B
est: 3.73B (-6.0%)
|
2.57B
est: 4.11B (-37.3%)
|
2.93B
est: 4.46B (-34.4%)
|
3.37B
est: 4.85B (-30.5%)
|
3.68B
est: 3.44B (+7.2%)
|
3.44B
3.44B – 3.44B
+0.0% YoY
|
3.49B
3.49B – 3.49B
+1.5% YoY
|
3.57B
3.57B – 3.57B
+2.5% YoY
|
3.67B
3.67B – 3.67B
+2.8% YoY
|
3.73B
3.73B – 3.73B
+1.6% YoY
|
4.11B
4.11B – 4.11B
+10.0% YoY
|
| EBITDA |
218.67M
est: 308.50M (-29.1%)
|
224.31M
est: 400.07M (-43.9%)
|
237.64M
est: 409.39M (-42.0%)
|
268.29M
est: 415.39M (-35.4%)
|
321.34M
est: 425.66M (-24.5%)
|
275.93M
est: 437.57M (-36.9%)
|
322.55M
est: 444.63M (-27.5%)
|
334.69M
est: 489.09M (-31.6%)
|
307.45M
est: 375.82M (-18.2%)
|
435.65M
est: 580.35M (-24.9%)
|
388.69M
est: 363.51M (+6.9%)
|
363.51M
363.51M – 363.51M
+0.0% YoY
|
368.83M
368.83M – 368.83M
+1.5% YoY
|
377.95M
377.95M – 377.95M
+2.5% YoY
|
388.53M
388.53M – 388.53M
+2.8% YoY
|
394.80M
394.80M – 394.80M
+1.6% YoY
|
434.28M
434.28M – 434.28M
+10.0% YoY
|
| EBIT |
176.37M
est: 270.28M (-34.7%)
|
222.05M
est: 350.51M (-36.6%)
|
251.25M
est: 358.67M (-29.9%)
|
281.24M
est: 363.93M (-22.7%)
|
284.96M
est: 372.93M (-23.6%)
|
238.51M
est: 383.36M (-37.8%)
|
289.66M
est: 389.55M (-25.6%)
|
313.63M
est: 428.50M (-26.8%)
|
286.14M
est: 298.73M (-4.2%)
|
315.79M
est: 508.45M (-37.9%)
|
309.19M
est: 301.22M (+2.6%)
|
301.22M
301.22M – 301.22M
+0.0% YoY
|
305.63M
305.63M – 305.63M
+1.5% YoY
|
313.19M
313.19M – 313.19M
+2.5% YoY
|
321.95M
321.95M – 321.95M
+2.8% YoY
|
327.15M
327.15M – 327.15M
+1.6% YoY
|
359.86M
359.86M – 359.86M
+10.0% YoY
|
| Net Income |
127.91M
est: 115.51M (+10.7%)
|
163.15M
est: 168.35M (-3.1%)
|
183.42M
est: 180.26M (+1.7%)
|
203.95M
est: 237.42M (-14.1%)
|
191.05M
est: 212.07M (-9.9%)
|
165.39M
est: 209.85M (-21.2%)
|
212.54M
est: 209.63M (+1.4%)
|
236.58M
est: 240.39M (-1.6%)
|
212.50M
est: 254.03M (-16.3%)
|
273.41M
est: 276.48M (-1.1%)
|
228.18M
est: 180.39M (+26.5%)
|
180.39M
180.39M – 180.39M
+0.0% YoY
|
237.58M
237.58M – 237.58M
+31.7% YoY
|
212.22M
212.22M – 212.22M
-10.7% YoY
|
209.99M
209.99M – 209.99M
-1.1% YoY
|
209.78M
209.78M – 209.78M
-0.1% YoY
|
240.55M
240.55M – 240.55M
+14.7% YoY
|
| SGA |
207.74M
est: 158.59M (+31.0%)
|
153.74M
est: 205.67M (-25.2%)
|
131.00M
est: 210.46M (-37.8%)
|
127.20M
est: 213.54M (-40.4%)
|
155.49M
est: 218.82M (-28.9%)
|
144.05M
est: 224.95M (-36.0%)
|
167.84M
est: 228.58M (-26.6%)
|
125.87M
est: 251.43M (-49.9%)
|
148.63M
est: 466.93M (-68.2%)
|
174.58M
est: 298.35M (-41.5%)
|
360.87M
est: 278.81M (+29.4%)
|
278.81M
278.81M – 278.81M
+0.0% YoY
|
282.89M
282.89M – 282.89M
+1.5% YoY
|
289.89M
289.89M – 289.89M
+2.5% YoY
|
298.00M
298.00M – 298.00M
+2.8% YoY
|
302.81M
302.81M – 302.81M
+1.6% YoY
|
333.09M
333.09M – 333.09M
+10.0% YoY
|
| EPS |
12.06
est: 10.89 (+10.7%)
|
15.38
est: 15.51 (-0.8%)
|
17.29
est: 17.00 (+1.7%)
|
19.10
est: 22.39 (-14.7%)
|
18.01
est: 20.00 (-9.9%)
|
15.59
est: 19.79 (-21.2%)
|
20.03
est: 19.77 (+1.3%)
|
22.30
est: 22.67 (-1.6%)
|
20.03
est: 24.20 (-17.2%)
|
25.77
est: 25.84 (-0.3%)
|
21.52
est: 17.00 (+26.6%)
|
17.00
17.00 – 17.00
+0.0% YoY
|
22.39
22.39 – 22.39
+31.7% YoY
|
20.00
20.00 – 20.00
-10.7% YoY
|
19.79
19.79 – 19.79
-1.1% YoY
|
19.77
19.77 – 19.77
-0.1% YoY
|
22.67
22.67 – 22.67
+14.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gaurav Goenka | Joint MD, Chief Executive Officer & Director | 19M | male |
| Shiv Shankar Poddar | Founder, MD & Executive Director | 16M | male |
| Manoj Kumar Paharia | Chief Commercial Officer | — | male |
| Pankaj Mudgal | Chief Marketing Officer | — | male |
| Rajeev Kumar | Company Secretary & Compliance Officer | — | male |
| Sachin Shivprasad Gattani | Chief Operating Officer | — | male |
| Alok Behari Mathur | Vice President of Technical | — | male |
| Yug Mahesshwari | Chief Financial Officer | — | male |
| Bimal Kumar Choudhary | Senior General Manager of Comm. & Admin | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PODDARMENT.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
